nisoldipine
Selected indexed studies
- Nisoldipine: a new dihydropyridine calcium-channel blocker. (J Clin Pharmacol, 1993) [PMID:8429113]
- Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. (Cardiovasc Drugs Ther, 1997) [PMID:9126676]
- Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease. (Drugs, 1997) [PMID:9129871]
_Worker-drafted node — pending editorial review._
Connections
nisoldipine is a side effect of
Sources
- Nisoldipine: a new dihydropyridine calcium-channel blocker. (1993) pubmed
- Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. (1997) pubmed
- Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease. (1997) pubmed
- Clinical pharmacokinetics of nisoldipine coat-core. (1998) pubmed
- The pharmacology of nisoldipine. (1987) pubmed
- Nisoldipine CC: clinical experience in hypertension. (1997) pubmed
- Nisoldipine CC: clinical experience in ischaemic heart disease. (1997) pubmed
- Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process. (2022) pubmed
- Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension. (1996) pubmed
- Nisoldipine exposures. (2008) pubmed